How Does Georgia’s Collateral Source Rule Work and Does It Prevent a Defendant From Reducing a Damages Award Because the Plaintiff Had Health Insurance?
The collateral source rule is a long-standing principle in Georgia tort law that prevents a defendant from reducing a plaintiff’s damages award simply because the plaintiff received compensation for the same losses from an independent third party such as a health insurer. Note: Georgia’s 2025 tort reform (SB 68) introduced significant changes to how medical expenses are presented to juries for causes of action arising after April 21, 2025.
Definition of the Collateral Source Rule in Georgia
The collateral source rule provides that compensation received by the plaintiff from sources independent of the tortfeasor cannot be used to reduce the tortfeasor’s liability. The rationale is that a wrongdoer should not benefit from the injured party’s foresight in obtaining insurance or from benefits that the plaintiff earned independently. If the plaintiff has health insurance that paid $50,000 in medical bills, the defendant cannot argue that the plaintiff’s damages should be reduced by that amount.
Why Georgia Prohibits Defendants From Benefiting From Plaintiff’s Insurance
The rule serves two purposes. First, it ensures that the tortfeasor bears the full cost of the harm they caused, providing appropriate deterrence. Second, it prevents the tortfeasor from receiving a windfall because the plaintiff was prudent enough to obtain insurance. The plaintiff paid premiums for their insurance coverage, and the defendant should not be the beneficiary of that investment.
Application to Health Insurance Payments for Accident-Related Treatment
When a plaintiff’s health insurance pays for accident-related medical treatment, the collateral source rule traditionally prevented the defendant from introducing evidence of those payments to reduce the damages. The jury would see the full billed amount of the medical charges rather than the lower amount actually paid by the insurer. However, SB 68 (effective for causes of action arising after April 21, 2025) changed this by allowing juries to consider both the amounts charged and the amounts actually necessary to satisfy those charges under the plaintiff’s public or private health insurance, including workers’ compensation benefits. This means that workers’ compensation payment amounts, previously shielded by the collateral source rule, may now be presented to the jury for the purpose of determining the reasonable value of medical treatment in post-April 2025 claims.
SB 68 also introduced new discovery rules for treatment obtained under letters of protection. When a plaintiff receives medical treatment under a letter of protection arrangement, in which a healthcare provider agrees to defer payment until a settlement or judgment is obtained, the following information is now relevant and discoverable: the letter of protection agreement itself, an itemized list of medical services provided with specific charges and billing codes, the name and dollar amount of any portion of the account receivable sold to a third party, and the identity of any individual who referred the plaintiff to the provider for treatment. These provisions give defendants significantly more visibility into the financial arrangements behind the plaintiff’s medical treatment.
Application to Workers’ Compensation Benefits
Workers’ compensation benefits paid to an injured employee are a collateral source. The defendant cannot reduce their liability by the amount of workers’ compensation benefits the plaintiff received. However, the workers’ compensation insurer has a separate subrogation right that allows it to recover from the tort settlement, which effectively prevents double recovery without reducing the defendant’s obligation.
Application to Disability Insurance and Government Benefits
Disability insurance benefits, Social Security disability payments, and other government benefits are collateral sources. The defendant cannot use these payments to reduce the plaintiff’s damages award. Each of these benefits was earned or purchased by the plaintiff independently of the defendant’s conduct.
How the Collateral Source Rule Affects the Damages Evidence at Trial
The collateral source rule traditionally controlled what evidence the jury could see regarding the plaintiff’s medical expenses. Under the old rule, the jury typically saw only the full billed amount. Under SB 68 for post-April 2025 causes of action, the jury may see both the billed amount and the amount paid or accepted by the provider, and must determine the “reasonable value” of the care. This change directly affects the size of the medical expenses component of the damages award.
Medical Bills: Charged Amount Versus Paid Amount Controversy
The gap between what healthcare providers charge (the “sticker price”) and what insurance actually pays (the negotiated rate) can be substantial. A hospital may bill $100,000 for treatment but accept $30,000 from the insurer as payment in full. Under the traditional collateral source rule, the plaintiff could present the $100,000 figure to the jury. Critics called this “phantom damages” because the plaintiff’s actual financial exposure was far less than the billed amount. SB 68 addressed this by allowing both figures to be presented for post-April 2025 claims.
Georgia Court Decisions on the Charged Versus Paid Debate
Before SB 68, Georgia courts addressed the billed-versus-paid controversy in several decisions that reflected the growing tension between the traditional collateral source rule and the reality of modern healthcare pricing. The Georgia Court of Appeals and the Georgia Supreme Court both grappled with cases where defense attorneys argued that the jury should see only what was actually paid, while plaintiffs argued the full billed amount was the proper measure. Courts generally applied the collateral source rule to permit the billed amount, reasoning that the defendant should not benefit from the plaintiff’s insurance. However, some decisions acknowledged that the gap between billed and paid amounts had grown so large that allowing the full billed amount risked awarding “phantom damages” that bore no relationship to the actual economic harm. In Olariu v. Marrero (2018), the Court of Appeals examined the interplay between the collateral source rule and the “reasonable value” standard for medical damages, signaling that the issue needed legislative resolution. SB 68 resolved this tension for new claims by permitting both amounts to be presented to the jury, effectively splitting the difference: the jury sees both the full charges and the paid amounts, and determines the “reasonable value” of the care. This compromise gives the defense the transparency it sought while preserving the plaintiff’s ability to argue that the billed amount reflects the true value of the services rendered.
How Defense Attorneys Try to Introduce Insurance Evidence
Defense attorneys have historically sought to introduce evidence of the plaintiff’s insurance coverage to reduce the perceived damages. The collateral source rule generally bars this evidence, and the trial court excludes it on the plaintiff’s objection. SB 68 modified the rule for medical expenses by allowing certain insurance-related evidence, but the broader collateral source rule remains intact for other types of collateral benefits.
Subrogation Rights and How They Interact With the Collateral Source Rule
Subrogation rights allow an insurer that paid benefits to the plaintiff to recover from the tort settlement. The collateral source rule prevents the defendant from benefiting, but subrogation prevents the plaintiff from obtaining a double recovery. The insurer’s subrogation claim is satisfied from the settlement proceeds, reducing the plaintiff’s net recovery but not the defendant’s liability.
Legislative Attempts to Modify the Collateral Source Rule in Georgia
SB 68 represents the most significant modification to the collateral source rule in Georgia. The legislation allows the introduction of evidence regarding paid amounts for medical expenses, effectively modifying the traditional rule for that specific category of damages. The broader collateral source rule remains intact for other categories, and future legislative efforts may seek further modifications.
Strategic Implications of the Collateral Source Rule for Plaintiffs
For claims arising before SB 68’s effective date, the collateral source rule continues to allow the full billed amount to be presented. For post-April 2025 claims, plaintiffs must adapt their strategy to address the introduction of paid amounts and must present compelling evidence that the reasonable value of the medical care exceeds the insurance-negotiated rate. The choice of medical providers and the method of paying for treatment (health insurance versus letter of protection) becomes a strategic consideration with direct impact on the damages presentation.
This content is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by reading this material. Laws, regulations, and court interpretations change over time, and the information presented here may not reflect the most current legal developments. Every case involves unique facts and circumstances that require individualized analysis. If you have been involved in a vehicle accident in Georgia, consult a licensed Georgia attorney to discuss your specific situation and legal options.
